Keros Therapeutics Income Statement (2019-2025) | KROS

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 2.50M2.50M2.50M2.50M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M20.00M18.00M0.01M0.14M0.08M0.04M0.39M3.04M211.25M18.17M14.26M
Operating items
Research & Development 4.87M4.50M3.85M4.16M8.53M7.26M8.39M9.67M11.49M9.98M14.83M18.83M18.08M23.28M21.04M24.87M31.09M32.53M34.14M37.49M38.26M40.52M49.23M45.63M48.71M43.50M19.52M
Selling, General & Administrative 0.49M0.65M0.97M1.07M1.98M3.65M3.55M3.62M4.27M5.66M5.37M6.03M6.05M7.45M6.94M7.09M7.78M8.80M9.15M9.11M10.31M9.96M9.82M10.66M10.50M14.48M10.13M
Other Operating Expenses -0.60M-0.65M-1.24M-0.08M-1.49M
Operating Expenses 5.36M5.15M4.83M5.23M10.50M10.91M11.95M13.29M15.77M15.64M20.20M24.87M24.13M30.73M27.98M31.96M38.87M41.34M43.29M46.60M48.57M50.48M59.05M56.30M59.21M57.98M29.65M
Operating Income -2.86M-2.65M-2.33M-2.73M-10.50M-10.91M-11.95M-13.29M-15.77M-15.54M-20.20M-4.87M-24.13M-30.73M-27.98M-31.96M-38.87M-41.34M-43.28M-46.45M-48.48M-50.44M-58.66M-53.25M152.04M-39.82M-15.38M
EBIT -2.86M-2.65M-2.33M-2.73M-10.50M-10.91M-11.95M-13.29M-15.77M-15.54M-20.20M-4.87M-24.13M-30.73M-27.98M-31.96M-38.87M-41.34M-43.28M-46.45M-48.48M-50.44M-58.66M-53.25M152.04M-39.82M-15.38M
Non-operating items
Other Non Operating Income 0.10M0.07M0.01M0.06M-0.07M0.16M-0.09M0.16M-0.07M-0.08M-0.14M-0.10M-0.06M0.09M0.76M-1.40M-0.04M-0.15M-0.07M0.06M-0.44M-0.20M-0.09M-0.23M-0.34M-0.22M-0.25M
Non Operating Income -0.33M-0.20M-1.22M-0.02M-1.56M0.16M-0.09M2.62M-0.07M-0.08M-0.14M-0.10M-0.06M3.46M4.47M2.24M3.06M3.83M3.84M6.21M5.37M5.18M5.70M7.53M6.45M6.90M6.68M
Net income details
EBT -3.18M-2.85M-3.55M-2.75M-12.06M-10.76M-12.04M-10.68M-15.84M-15.62M-20.34M-4.94M-24.19M-27.27M-23.51M-29.72M-38.87M-41.34M-43.28M-46.45M-43.11M-45.26M-52.96M-45.73M158.49M-32.92M-8.70M
Tax Provisions -0.17M0.05M-0.04M2.00M0.30M10.04M-2.22M-1.42M
Profit After Tax -3.18M-2.85M-3.55M-2.75M-11.89M-10.76M-12.04M-10.68M-15.88M-15.62M-20.30M-6.94M-24.19M-27.27M-23.51M-29.72M-35.80M-37.51M-39.44M-40.24M-43.11M-45.26M-52.96M-46.03M148.45M-30.70M-7.28M
Income from Continuing Operations -3.18M-2.85M-3.55M-2.75M-11.89M-10.76M-12.04M-10.68M-15.88M-15.62M-20.30M-6.94M-24.19M-27.27M-23.51M-29.72M-38.87M-41.34M-43.28M-46.45M-43.11M-45.26M-52.96M-46.03M148.45M-30.70M-7.28M
Consolidated Net Income -3.18M-2.85M-3.55M-2.75M-11.89M-10.76M-12.04M-10.68M-15.88M-15.62M-20.30M-6.94M-24.19M-27.27M-23.51M-29.72M-38.87M-41.34M-43.28M-46.45M-43.11M-45.26M-52.96M-46.03M148.45M-30.70M-7.28M
Income towards Parent Company -3.18M-2.85M-3.55M-2.75M-11.89M-10.76M-12.04M-10.68M-15.88M-15.62M-20.30M-6.94M-24.19M-27.27M-23.51M-29.72M-38.87M-41.34M-43.28M-46.45M-43.11M-45.26M-52.96M-46.03M148.45M-30.70M-7.28M
Net Income towards Common Stockholders -3.63M-3.30M-4.00M-3.20M-12.70M-10.96M-12.04M-9.66M-15.88M-15.62M-20.30M-6.94M-24.19M-27.27M-23.51M-29.72M-35.80M-37.51M-39.44M-40.24M-43.11M-45.26M-52.96M-46.03M148.45M-30.70M-7.28M
Additional items
EPS (Basic) -1.61-1.44-1.71-1.32-5.11-0.62-0.60-0.28-0.68-0.67-0.87-0.30-1.01-1.13-0.92-1.10-1.26-1.27-1.33-1.34-1.21-1.25-1.41-1.123.66-0.76-0.18
EPS (Weighted Average and Diluted) -1.73-0.60-0.28-0.68-0.67-0.87-0.30-1.01-1.13-0.92-1.10-1.26-1.27-1.33-1.34-1.21-1.25-1.41-1.123.62-0.76-0.18
Shares Outstanding (Weighted Average) 18.19M18.19M20.15M20.19M20.19M23.27M23.30M23.34M23.40M24.00M24.03M25.76M27.54M28.54M29.58M29.66M29.96M35.98M36.08M37.52M40.51M40.56M40.62M40.62M
Shares Outstanding (Diluted Average) 17.62M20.18M15.51M23.23M23.31M23.36M23.33M23.99M24.05M25.55M25.24M28.37M29.60M29.67M29.45M35.69M36.10M37.59M37.44M41.02M41.15M41.20M
EBITDA -2.86M-2.65M-2.33M-2.73M-10.50M-10.91M-11.95M-13.29M-15.77M-15.54M-20.20M-4.87M-24.13M-30.73M-27.98M-31.96M-38.87M-41.34M-43.28M-46.45M-48.48M-50.44M-58.66M-53.25M152.04M-39.82M-15.38M
Interest Expenses 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Tax Rate 1.43%0.19%6.34%6.75%16.36%